| Accord Healthcare AG - Dasatinib Accord 50 mg, Filmtabletten | | 69965 | | 02 | | Dasatinib Accord 50 mg | | Filmtabletten | | L01EA02 | | Dasatinib | | 20.01.2025 | | |
| | Composition | | dasatinibum 50 mg ut dasatinibum monohydricum, lactosum monohydricum 65.654 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 0.72 mg, magnesii stearas, Überzug: hypromellosum, E 171, triacetinum, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Dasatinib | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 65.654 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 60 | DDP | DDP | A | | Non |
|
|
